Valbiotis SA (EPA:ALVAL)
0.8200
-0.0100 (-1.20%)
Nov 20, 2025, 5:35 PM CET
Valbiotis Market Cap
Valbiotis has a market cap or net worth of €19.4 million as of November 20, 2025. Its market cap has increased by 5.54% in one year.
Market Cap
19.40M
Enterprise Value
11.52M
Revenue
474.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.82
Market Cap Chart
Since June 7, 2017, Valbiotis's market cap has decreased from 35.48M to 19.40M, a decrease of -45.33%. That is a compound annual growth rate of -6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 19.63M | -18.05% |
| Dec 31, 2024 | 23.96M | -61.38% |
| Dec 29, 2023 | 62.05M | 38.94% |
| Dec 30, 2022 | 44.66M | -32.91% |
| Dec 31, 2021 | 66.56M | 42.91% |
| Dec 31, 2020 | 46.58M | 189.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.57B |
| Sartorius Stedim Biotech | 18.00B |
| bioMérieux | 12.50B |
| Ipsen | 10.43B |
| Eurofins Scientific SE | 10.18B |
| ABIVAX Société Anonyme | 7.32B |
| Virbac | 2.97B |